Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

InterSEPT: In-Tunnel SeptRx European PFO Trial: A Prospective, Multi-Center Study to Evaluate the Safety and Performance of the SeptRx IPO PFO Closure System

NCT01385670 is registered in ClinicalTrials.gov with SeptRx, Inc. as lead sponsor.

NCT NCT01385670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01385670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
InterSEPT: In-Tunnel SeptRx European PFO Trial: A Prospective, Multi-Center Study to Evaluate the Safety and Performance of the SeptRx IPO PFO Closure System
Lead sponsor
SeptRx, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2011
Completion date
Not reported
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

foramen ovale, patent, heart defects, congenital, heart septal defects